Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JFitnich who wrote (290)	8/26/2002 7:35:46 PM
From: tuck	Read Replies (2) of 598

Jason, You're not alone . . . Remember this? >>Message #277 from Doc Bones at Aug 13, 2002 8:11 AM 07:47 ET TLRK Tularik downgraded by B of A (8.79) Banc of America downgrades to MKT PERFORM from Buy; believes Aug 26 FDA meeting on the development plan for T-67 adds risk without commensurate reward; sees odds of an FDA endorsement of the T-67 Phase III trial at just 60-40.<< The latest (6:11PM) news item recaps the one you posted, and ends as follows: >>Shares of Tularik got a boost from the news after hours, recently trading at $ 9.09, according to Island ECN, up from Monday's closing price of $7.50. The shares bottomed to a year low of $6.28 last month. -Carrie Kocik; Dow Jones newswires; 201-938-5388<< Cheers, Tuck, who will take anything the market gives to Tularik, whether biofreaks can get excited about it or not.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next